Gary Jackson

Array ( [id] => 6280490 [patent_doc_number] => 20100119530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Regulation of TLR Signaling by Complement' [patent_app_type] => utility [patent_app_number] => 12/307560 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13947 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119530.pdf [firstpage_image] =>[orig_patent_app_number] => 12307560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904496 [patent_doc_number] => 20080113910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'RGD-ENRICHED GELATINE-LIKE PROTEINS WITH ENHANCED CELL BINDING' [patent_app_type] => utility [patent_app_number] => 11/770215 [patent_app_country] => US [patent_app_date] => 2007-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7432 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113910.pdf [firstpage_image] =>[orig_patent_app_number] => 11770215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 185306 [patent_doc_number] => 07645737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-12 [patent_title] => 'Drug delivery system comprising an RGD-enriched gelatine' [patent_app_type] => utility [patent_app_number] => 11/770197 [patent_app_country] => US [patent_app_date] => 2007-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7452 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/645/07645737.pdf [firstpage_image] =>[orig_patent_app_number] => 11770197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 274263 [patent_doc_number] => 07560427 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-14 [patent_title] => 'RGD-enriched gelatine-like proteins with enhanced cell binding' [patent_app_type] => utility [patent_app_number] => 11/770256 [patent_app_country] => US [patent_app_date] => 2007-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7476 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560427.pdf [firstpage_image] =>[orig_patent_app_number] => 11770256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343413 [patent_doc_number] => 20090182063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'RGD-ENRICHED GELATINE-LIKE PROTEINS WITH ENHANCED CELL BINDING' [patent_app_type] => utility [patent_app_number] => 11/770271 [patent_app_country] => US [patent_app_date] => 2007-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7433 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20090182063.pdf [firstpage_image] =>[orig_patent_app_number] => 11770271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4928083 [patent_doc_number] => 20080167446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'RGD-ENRICHED GELATINE-LIKE PROTEINS WITH ENHANCED CELL BINDING' [patent_app_type] => utility [patent_app_number] => 11/770019 [patent_app_country] => US [patent_app_date] => 2007-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7398 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167446.pdf [firstpage_image] =>[orig_patent_app_number] => 11770019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4698827 [patent_doc_number] => 20080221011 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Targeting complement factor H for treatment of diseases' [patent_app_type] => utility [patent_app_number] => 11/821370 [patent_app_country] => US [patent_app_date] => 2007-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 25847 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221011.pdf [firstpage_image] =>[orig_patent_app_number] => 11821370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4872664 [patent_doc_number] => 20080199398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Novel Peptides That Promote Lipid Efflux' [patent_app_type] => utility [patent_app_number] => 11/764619 [patent_app_country] => US [patent_app_date] => 2007-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 56784 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199398.pdf [firstpage_image] =>[orig_patent_app_number] => 11764619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4733481 [patent_doc_number] => 20080050460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Uses of lectin-conotoxin' [patent_app_type] => utility [patent_app_number] => 11/811218 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 10026 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050460.pdf [firstpage_image] =>[orig_patent_app_number] => 11811218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4688204 [patent_doc_number] => 20080032385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-07 [patent_title] => 'Novel antimicrobial peptide isolated from Penaeus monodon' [patent_app_type] => utility [patent_app_number] => 11/806234 [patent_app_country] => US [patent_app_date] => 2007-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12076 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20080032385.pdf [firstpage_image] =>[orig_patent_app_number] => 11806234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5045678 [patent_doc_number] => 20070264351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier' [patent_app_type] => utility [patent_app_number] => 11/802197 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10784 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264351.pdf [firstpage_image] =>[orig_patent_app_number] => 11802197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725517 [patent_doc_number] => 08404632 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Compositions and methods for the delivery of nitric oxide' [patent_app_type] => utility [patent_app_number] => 12/302004 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 57 [patent_no_of_words] => 37929 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12302004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725516 [patent_doc_number] => 08404631 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Compositions and methods for the delivery of oxygen' [patent_app_type] => utility [patent_app_number] => 12/302002 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 37075 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12302002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 292186 [patent_doc_number] => 07544475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => 'Depression gene' [patent_app_type] => utility [patent_app_number] => 11/750019 [patent_app_country] => US [patent_app_date] => 2007-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26765 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544475.pdf [firstpage_image] =>[orig_patent_app_number] => 11750019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391292 [patent_doc_number] => 20090208605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'CONTINUOUS METHOD OF PRODUCING A MASH EXTRACT' [patent_app_type] => utility [patent_app_number] => 12/301440 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8274 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208605.pdf [firstpage_image] =>[orig_patent_app_number] => 12301440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5428565 [patent_doc_number] => 20090087875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'Alzheimer\'s related proteins and methods of use' [patent_app_type] => utility [patent_app_number] => 11/801893 [patent_app_country] => US [patent_app_date] => 2007-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9446 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087875.pdf [firstpage_image] =>[orig_patent_app_number] => 11801893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 366801 [patent_doc_number] => 07479541 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-20 [patent_title] => 'Human and murine Mus81 proteins' [patent_app_type] => utility [patent_app_number] => 11/800929 [patent_app_country] => US [patent_app_date] => 2007-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 14122 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/479/07479541.pdf [firstpage_image] =>[orig_patent_app_number] => 11800929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 252532 [patent_doc_number] => 07579164 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-25 [patent_title] => 'Optimization of coronatine production in a genetically improved strain of Pseudomonas syringae' [patent_app_type] => utility [patent_app_number] => 11/740029 [patent_app_country] => US [patent_app_date] => 2007-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 9732 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/579/07579164.pdf [firstpage_image] =>[orig_patent_app_number] => 11740029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 369764 [patent_doc_number] => 07476537 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-13 [patent_title] => 'Thermophilic hydrophobin proteins and applications for surface modification' [patent_app_type] => utility [patent_app_number] => 11/788351 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13299 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/476/07476537.pdf [firstpage_image] =>[orig_patent_app_number] => 11788351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4745242 [patent_doc_number] => 20080089844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Kappam-conopeptides as organ protectants' [patent_app_type] => utility [patent_app_number] => 11/785574 [patent_app_country] => US [patent_app_date] => 2007-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11879 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20080089844.pdf [firstpage_image] =>[orig_patent_app_number] => 11785574 [rel_patent_id] =>[rel_patent_doc_number] =>)